Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART27.13 crossover study in ocular hypertension or early primary open-angle glaucoma
ISRCTN10996483Phase 2Recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- May 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of AZD-1940 in ocular hypertension and open-angle glaucoma (OAG) (2 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Intraocular pressure. Started May 2026; status: recruiting.
02
Drugs
AZD-1940
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on ISRCTN10996483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10996483.